The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Caffeine: A Model Compound for Measuring Liver Function
Open accessAbstract
The effects of liver disease on caffeine plasma clearance (CI) and on exhalation of 14 CO 2 following i.v. injection of 2 μCi of [ 3-methyl-14 C]caffeine together with 125 mg of the unlabeled compound were measured in 15 patients with cirrhosis, 11 subjects with miscellaneous liver disease, and 10 normal volunteers. Compared to mean values for CI (2.02 ± S.D. 0.68 ml per min per kg) and t½ (3.8 ± 0.9 hr) in normal volunteers, cirrhotics were characterized by highly significant reductions in CI (to 0.76 ± 0.40) and prolongation in t½ (to 13.7 ± 13.0), whereas the volume of distribution (VD) remained relatively unchanged (0.57 ± 0.16 vs. 0.64 ± 0.13 liter per kg in normals). Cumulative 14 CO 2 production and specific activity of 14 CO 2 in breath decreased in parallel (r = 0.83) with Cl. Patients with miscellaneous liver disease exhibited only small changes in Cl and t½; however, 14 CO 2 parameters in breath appeared more sensitive in indicating the slight functional derangement. In view of the correlation (R s = 0.83) of cumulative 14 CO 2 excretion with the initial disappearance constant for bromosulfophthalein, the caffeine breath test may be considered as a quantitative measure of hepatic microsomal activity; based on a surprisingly close, hyperbolic relationship between Cl and fasting caffeine plasma concentrations, the latter might serve as a simple guide to severity of liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The absolute bioavailability of caffeine in man
Blanchard, J., & Sawers, S. J. A. (1983) · European Journal of Clinical Pharmacology · doi:10.1007/bf00613933 · Cited by 378
Caffeine disposition after oral doses
Bonati, M., Latini, R., Galletti, F., Young, J. F., Tognoni, G., & Garattini, S. (1982) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1982.132 · Cited by 353 · cited 2×
“Its pharmacokinetics in normal man are now well elucidated (10, 12) and, as expected, its plasma disappearance in subjects with cirrhosis is delayed (13).”
BackgroundResultEffect of smoking on caffeine clearance
Parsons, W. D., & Neims, A. H. (1978) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt197824140 · Cited by 302 · cited 1×
“It was not unreasonable, therefore, to anticipate that the enzyme induction produced by smoking (20-22) might-at least in part-counteract the effects of liver disease on the CBT.”
Background
Cited by
Pharmacokinetics and dosage adjustment in patients with renal dysfunction
Verbeeck, R. K., & Musuamba, F. T. (2009) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-009-0678-8 · Cited by 717
Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction
Verbeeck, R. K. (2008) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-008-0553-z · Cited by 652
Streetman, D. S., Bertino, J. S., & Nafziger, A. N. (2000) · Pharmacogenetics · doi:10.1097/00008571-200004000-00001 · Cited by 425
Pharmacokinetics and metabolism of natural methylxanthines in animal and man
Arnaud, M. J. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-13443-2_3 · Cited by 259
Dose Adjustment in Patients with Liver Disease
Delc??, F., Tchambaz, L., Schlienger, R., Drewe, J., & Kr??henb??hl, S. (2005) · Drug Safety · doi:10.2165/00002018-200528060-00005 · Cited by 256
Metadata
- Authors
- Renner, E., Wietholtz, H., Huguenin, P., Arnaud, M. J., & Preisig, R.
- Venue
- Hepatology
- Published
- 1984-01
- Volume
- 4
- Issue
- 1
- Pages
- 38-46
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1986398072
- Cited by
- 171
- References
- 3
- FWCI
- 6.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Caffeine: A Model Compound for Measuring Liver Function. https://app.cochat.ai/papers/10.1002/hep.1840040107
- The paper
- Renner, E., Wietholtz, H., Huguenin, P., Arnaud, M. J., & Preisig, R. (1984). Caffeine: A Model Compound for Measuring Liver Function. Hepatology. https://doi.org/10.1002/hep.1840040107
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.